Trial Profile
Study of Neural Responses Induced by Simulated Antidepressants
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Nov 2022
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms SONRISA
- 04 Jun 2021 Status changed from recruiting to completed.
- 09 Apr 2021 Planned End Date changed from 1 Nov 2021 to 1 May 2021.
- 09 Apr 2021 Planned primary completion date changed from 1 Sep 2021 to 1 May 2021.